FDA briefing docs on ONXX’s Kyprolis (carfilzomib): http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM308563.pdf http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm308560.htm The panel meeting on Wednesday will be webcast.